Toshifumi Matsuyama
Research Subjects
Toshifumi Matsuyama has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
Tomoko Kohno
Division of Cytokine Signaling, Department of Molecular Microbiology and Immunology, Nagasaki University, Graduate School of Biomedical Sciences, 1-12-4 Sakamoto, Nagasaki 852-8523, Japan
4 shared publicationsKazuo Yamamoto
3 shared publicationsMasao Tomonaga
Department of Hematology, Nagasaki University, Graduate School of Biomedical Sciences, 1-12-4 Sakamoto, Nagasaki 852-8523, Japan
3 shared publicationsYoshitaka Imaizumi
Department of Hematology, Nagasaki University, Graduate School of Biomedical Sciences, 1-12-4 Sakamoto, Nagasaki 852-8523, Japan
3 shared publicationsYasuaki Yamada
Department of Laboratory Medicine; and
2 shared publicationsAtsushi Kumatori
Departments of *Host-Defense Biochemistry and ∥Pathology, **Central Laboratory, Institute of Tropical Medicine, †Division of Immunology, Department of Translational Medical Sciences, ‡Department of Molecular Microbiology and Immunology, and ††Electron Microscope Center, Graduate School of Biomedical Sciences, Nagasaki University, 1-12-4 Sakamoto, Nagasaki 852-8523, Japan; and ¶Laboratory of Biodefense, National Institute of Infectious Diseases, 1-23-1 Toyama, Shinjuku-ku, Tokyo 162-8640, Japan
1 shared publication
Latest Publications
- Open Access
- 12 August 2005
- Published by Wiley in Cancer Science
- Vol. 96 (8) , 527-533
Possible origin of adult T‐cell leukemia/lymphoma cells from human T lymphotropic virus type‐1‐infected regulatory T cells
Adult T‐cell leukemia/lymphoma (ATLL) is a lymphoproliferative disorder caused by human T lymphotropic virus type 1 (HTLV‐I). Although ATLL cells display an activated helper/inducer T‐cell phenotype, CD4+ and CD25+, they are known to exhibit strong immunosuppressive activity. As regulatory T cells (Treg cells) express CD4+ and CD25+ molecules and possess potent immune response suppressive activity, we investigated a possible link between ATLL cells and Treg cells. In primary ATLL cells, the expression levels of the Treg cell marker molecules Foxp3 and glucocorticoid‐induced tumor necrosis factor receptor family related protein (GITR) were significantly higher than in those from healthy adults. Furthermore, ATLL cells are unresponsive in vitro to concanavalin A stimulation and suppress the proliferation of normal T cells. GITR mRNA expression was induced by the HTLV‐I transactivator Tax, and GITR promoter analyses revealed that this induction depends on the κB site from −431 bp to −444 bp upstream of the putative transcription site. Taken together, ATLL cells may originate from HTLV‐I‐infected Treg cells, and GITR seems to be involved in the progression to ATLL. (Cancer Sci 2005; 96: 527–533)
- 12 August 2005
- Published by Wiley in Cancer Science
- Vol. 96 (8) , 527-533
Open AccessPossible origin of adult T‐cell leukemia/lymphoma cells from human T lymphotropic virus type‐1‐infected regulatory T cells
Adult T‐cell leukemia/lymphoma (ATLL) is a lymphoproliferative disorder caused by human T lymphotropic virus type 1 (HTLV‐I). Although ATLL cells display an activated helper/inducer T‐cell phenotype, CD4+ and CD25+, they are known to exhibit strong immunosuppressive activity. As regulatory T cells (Treg cells) express CD4+ and CD25+ molecules and possess potent immune response suppressive activity, we investigated a possible link between ATLL cells and Treg cells. In primary ATLL cells, the expression levels of the Treg cell marker molecules Foxp3 and glucocorticoid‐induced tumor necrosis factor receptor family related protein (GITR) were significantly higher than in those from healthy adults. Furthermore, ATLL cells are unresponsive in vitro to concanavalin A stimulation and suppress the proliferation of normal T cells. GITR mRNA expression was induced by the HTLV‐I transactivator Tax, and GITR promoter analyses revealed that this induction depends on the κB site from −431 bp to −444 bp upstream of the putative transcription site. Taken together, ATLL cells may originate from HTLV‐I‐infected Treg cells, and GITR seems to be involved in the progression to ATLL. (Cancer Sci 2005; 96: 527–533)
- Open Access
- 1 May 2005
- Published by Oxford University Press (OUP) in Biology of Reproduction
- Vol. 72 (5) , 1282-1288
Induction of Epithelial Cell Apoptosis in the Uterus by a Mouse Uterine Ischemia-Reperfusion Model: Possible Involvement of Tumor Necrosis Factor-α
Menstruation in primates is preceded by a period of intense vasoconstriction, with resultant ischemia-reperfusion. Although apoptosis is involved in
- 1 May 2005
- Published by Oxford University Press (OUP) in Biology of Reproduction
- Vol. 72 (5) , 1282-1288
Open AccessInduction of Epithelial Cell Apoptosis in the Uterus by a Mouse Uterine Ischemia-Reperfusion Model: Possible Involvement of Tumor Necrosis Factor-α
Menstruation in primates is preceded by a period of intense vasoconstriction, with resultant ischemia-reperfusion. Although apoptosis is involved in
- Open Access
- 1 May 2005
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 280 (18) , 18355-18360
Role of Cyclophilin B in Activation of Interferon Regulatory Factor-3
- 1 May 2005
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 280 (18) , 18355-18360
Open AccessRole of Cyclophilin B in Activation of Interferon Regulatory Factor-3
- 7 June 2004
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 101 (24) , 8981-8986
Critical roles of interferon regulatory factor 4 in CD11bhighCD8α–dendritic cell development
IFN regulatory factors (IRFs) are a family of transcription factors that play an essential role in the homeostasis and function of immune systems. Recent studies indicated that IRF-8 is critical for the development of CD11blowCD8α+conventional dendritic cells (DCs) and plasmacytoid DCs. Here we show that IRF-4 is important for CD11bhighCD8α–conventional DCs. The development of CD11bhighDCs from bone marrow of IRF-4–/–mice was severely impaired in two culture systems supplemented with either GM-CSF or Flt3-ligand. In the IRF-4–/–spleen, the number of CD4+CD8α–DCs, a major subset of CD11bhighDCs, was severely reduced. IRF-4 and IRF-8 were expressed in the majority of CD11bhighCD4+CD8α–DCs and CD11blowCD8α+DCs, respectively, in a mutually exclusive manner. These results imply that IRF-4 and IRF-8 selectively play critical roles in the development of the DC subsets that express them.
- 7 June 2004
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 101 (24) , 8981-8986
Critical roles of interferon regulatory factor 4 in CD11bhighCD8α–dendritic cell development
IFN regulatory factors (IRFs) are a family of transcription factors that play an essential role in the homeostasis and function of immune systems. Recent studies indicated that IRF-8 is critical for the development of CD11blowCD8α+conventional dendritic cells (DCs) and plasmacytoid DCs. Here we show that IRF-4 is important for CD11bhighCD8α–conventional DCs. The development of CD11bhighDCs from bone marrow of IRF-4–/–mice was severely impaired in two culture systems supplemented with either GM-CSF or Flt3-ligand. In the IRF-4–/–spleen, the number of CD4+CD8α–DCs, a major subset of CD11bhighDCs, was severely reduced. IRF-4 and IRF-8 were expressed in the majority of CD11bhighCD4+CD8α–DCs and CD11blowCD8α+DCs, respectively, in a mutually exclusive manner. These results imply that IRF-4 and IRF-8 selectively play critical roles in the development of the DC subsets that express them.
- Open Access
- 1 February 2002
- Published by Oxford University Press (OUP) in International Immunology
- Vol. 14 (2) , 147-155
Human T cell leukemia virus type-I Tax activates human macrophage inflammatory protein-3α/CCL20 gene transcription via the NF-κB pathway
Infection by human T cell leukemia virus type (HTLV)-I is associated with several diseases, including adult T cell leukemia and HTLV-I-associated myelopathy/tropical spastic paraparesis. Leukocytes are attracted to the sites of inflammation by chemotactic factors. Macrophage inflammatory protein (MIP)-3α/CCL20 is a recently isolated member of the CC subfamily of chemokines and has been proposed as a crucial factor to elicit inflammatory reactions. We now report that endogenous MIP-3α mRNA levels are elevated in HTLV-I-infected T cell lines and in a human T cell line following the induced expression of the HTLV-I-encoded transactivator, Tax. Analysis of the human MIP-3α promoter revealed that this gene is activated by Tax, via the activation of nuclear factor (NF)-κB, whose responsive element, –82-κB, is located at a position between –82 and –91 relative to the putative transcription start site. With an electromobility shift assay we further demonstrated that the –82-κB element was bound by the Tax-activated p50/p65 heterodimers of NF-κB. Expression of the specific receptor of MIP-3α, CCR6, was also increased in HTLV-I-infected T cell lines, suggesting an autocrine and/or paracrine mechanism to establish the pathogenesis of HTLV-I-associated diseases.
- 1 February 2002
- Published by Oxford University Press (OUP) in International Immunology
- Vol. 14 (2) , 147-155
Open AccessHuman T cell leukemia virus type-I Tax activates human macrophage inflammatory protein-3α/CCL20 gene transcription via the NF-κB pathway
Infection by human T cell leukemia virus type (HTLV)-I is associated with several diseases, including adult T cell leukemia and HTLV-I-associated myelopathy/tropical spastic paraparesis. Leukocytes are attracted to the sites of inflammation by chemotactic factors. Macrophage inflammatory protein (MIP)-3α/CCL20 is a recently isolated member of the CC subfamily of chemokines and has been proposed as a crucial factor to elicit inflammatory reactions. We now report that endogenous MIP-3α mRNA levels are elevated in HTLV-I-infected T cell lines and in a human T cell line following the induced expression of the HTLV-I-encoded transactivator, Tax. Analysis of the human MIP-3α promoter revealed that this gene is activated by Tax, via the activation of nuclear factor (NF)-κB, whose responsive element, –82-κB, is located at a position between –82 and –91 relative to the putative transcription start site. With an electromobility shift assay we further demonstrated that the –82-κB element was bound by the Tax-activated p50/p65 heterodimers of NF-κB. Expression of the specific receptor of MIP-3α, CCR6, was also increased in HTLV-I-infected T cell lines, suggesting an autocrine and/or paracrine mechanism to establish the pathogenesis of HTLV-I-associated diseases.
- 1 December 2001
- Published by Wiley in Japanese Journal of Cancer Research
- Vol. 92 (12) , 1284-1292
Possible Involvement of Interferon Regulatory Factor 4 (IRF4) in a Clinical Subtype of Adult T‐Cell Leukemia
Interferon regulatory factor (IRF) 4 is the lymphoid‐specific transcription factor that is required for the proliferation of mitogen‐activated T cells. IRF4 has been suggested to be involved in tuniorigenesis because the overexpression of IRF4 caused the transformation of Rat‐1 fibroblasts in vitro. Here, we show that IRF4 is constitutively expressed in adult T‐cell leukemia (ATL)‐derived cell lines, which were infected with human T‐cell leukemia virus type‐I, but hardly expressed the trans‐activator protein, Tax. Similarly, constitutive expression of IRF4 was demonstrated in freshly isolated peripheral blood mononuclear cells (PBMC) from patients with either acute or chronic ATL. However, the high‐level expression of IRF4 was specifically associated with acute ATL. With mitogen‐activated PBMC from healthy donors, cell cycle analyses revealed that the induction of IRF4 occurred prior to cell cycle progression and the cells that had entered the cell cycle were predominantly IRF4‐positive cells. In addition, ectopic expression of IRF4 in Rat‐1 fibroblasts increased the S and G2/M phase population significantly. Taken together, our results indicate that IRF4 is involved in the pathogenesis of ATL through its positive effect on the cell cycle, and that IRF4 can be used as a molecular marker of clinical subtype in ATL.
- 1 December 2001
- Published by Wiley in Japanese Journal of Cancer Research
- Vol. 92 (12) , 1284-1292
Possible Involvement of Interferon Regulatory Factor 4 (IRF4) in a Clinical Subtype of Adult T‐Cell Leukemia
Interferon regulatory factor (IRF) 4 is the lymphoid‐specific transcription factor that is required for the proliferation of mitogen‐activated T cells. IRF4 has been suggested to be involved in tuniorigenesis because the overexpression of IRF4 caused the transformation of Rat‐1 fibroblasts in vitro. Here, we show that IRF4 is constitutively expressed in adult T‐cell leukemia (ATL)‐derived cell lines, which were infected with human T‐cell leukemia virus type‐I, but hardly expressed the trans‐activator protein, Tax. Similarly, constitutive expression of IRF4 was demonstrated in freshly isolated peripheral blood mononuclear cells (PBMC) from patients with either acute or chronic ATL. However, the high‐level expression of IRF4 was specifically associated with acute ATL. With mitogen‐activated PBMC from healthy donors, cell cycle analyses revealed that the induction of IRF4 occurred prior to cell cycle progression and the cells that had entered the cell cycle were predominantly IRF4‐positive cells. In addition, ectopic expression of IRF4 in Rat‐1 fibroblasts increased the S and G2/M phase population significantly. Taken together, our results indicate that IRF4 is involved in the pathogenesis of ATL through its positive effect on the cell cycle, and that IRF4 can be used as a molecular marker of clinical subtype in ATL.